INmune Bio Newsroom

INmune Bio Inc. Announces Final Enrollment of 208 Patients in Phase 2 Trial in Early Alzheimer's Disease

GlobeNewswireNov 13 09:00 ET

Inmune Bio Emerges as Biotech Innovator in 2023

TipRanksNov 13 06:30 ET

INmune Bio Holds an Investor and Analyst Webinar

TipRanksNov 7 11:20 ET

Maxim Group Maintains INmune Bio(INMB.US) With Buy Rating, Maintains Target Price $22

Moomoo NewsNov 7 08:31 ET · Ratings

Inmune Bio's Promising Pipeline and Financial Stability Justify Buy Rating

TipRanksNov 7 08:05 ET · Ratings

INmune Bio | 8-K: INmune Bio Inc. Announces Third Quarter 2024 Results and Provides Business Update

SECNov 1 16:27 ET

Earnings Call: INmune Bio Q3 2024 Results Show Progress in Clinical Trials

InvestingNov 1 10:42 ET

BTIG Maintains INmune Bio(INMB.US) With Buy Rating, Maintains Target Price $21

Moomoo NewsNov 1 08:35 ET · Ratings

Scotiabank Maintains INmune Bio(INMB.US) With Buy Rating, Maintains Target Price $22

Moomoo NewsNov 1 08:35 ET · Ratings

INmune Bio, Inc. (INMB) Q3 2024 Earnings Call Transcript Summary

moomoo AIOct 31 20:47 ET · Conference Call

INmune Bio GAAP EPS of -$0.60 Misses by $0.10

Seeking AlphaOct 31 16:12 ET

INmune Bio | 10-Q: Q3 2024 Earnings Report

SECOct 31 16:06 ET · Announcements

Express News | INmune Bio Q3 Operating Income USD -12.286 Million

ReutersOct 31 16:05 ET

Press Release: INmune Bio Inc. Announces Third Quarter 2024 Results and Provides Business Update

Dow JonesOct 31 16:05 ET

INmune Bio 3Q Loss/Shr 60c >INMB

Dow JonesOct 31 16:05 ET

Here Are the Major Earnings After the Close Today

Seeking AlphaOct 31 10:00 ET

INmune Bio Q3 2024 Earnings Preview

Seeking AlphaOct 30 17:35 ET

INmune Bio Inc. to Host Webinar on Cognitive Testing Using EMACC and CDR-SB

GlobeNewswireOct 28 08:00 ET

Earnings Preview: INmune Bio to Report Financial Results Post-market on October 31

Moomoo NewsOct 25 21:00 ET

Highbridge Capital Management's Strategic Acquisition of INmune Bio Inc Shares

Yahoo FinanceOct 25 13:02 ET